Clarifying the use of erythropoietic agents

J Support Oncol. 2004 May-Jun;2(3):200, 202; author reply 202.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anemia / blood
  • Anemia / chemically induced
  • Anemia / drug therapy
  • Antineoplastic Agents / adverse effects
  • Dose-Response Relationship, Drug
  • Erythropoietin / administration & dosage
  • Erythropoietin / standards
  • Erythropoietin / therapeutic use*
  • Hematinics / administration & dosage
  • Hematinics / standards
  • Hematinics / therapeutic use
  • Hemoglobins / drug effects
  • Hemoglobins / metabolism
  • Humans
  • Neoplasms / blood
  • Neoplasms / drug therapy

Substances

  • Antineoplastic Agents
  • Hematinics
  • Hemoglobins
  • Erythropoietin